ImmunityBio, Inc.

IBRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$143,428$265,453$104,641$181,101
Short-Term Investments$6,381$1,009$2,543$136,015
Receivables$2,653$3,168$1,890$1,333
Inventory$8,272$0$0$0
Other Curr. Assets$23,852$24,454$31,503$15,898
Total Curr. Assets$184,586$294,084$140,577$334,347
Property Plant & Equip (Net)$170,457$182,683$189,447$119,167
Goodwill$0$0$0$0
Intangibles$15,933$17,093$20,003$1,420
Long-Term Investments$0$891$840$7,597
Tax Assets$0$0$0$0
Other NC Assets$11,957$9,701$11,489$6,379
Total NC Assets$198,347$210,368$221,779$134,563
Other Assets$0$0$0$0
Total Assets$382,933$504,452$362,356$468,910
Liabilities
Payables$6,725$9,195$21,016$11,418
Short-Term Debt$7,466$5,244$434,551$302,247
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$40,753$43,844$45,294$55,330
Total Curr. Liab.$54,944$58,283$500,861$368,995
LT Debt$496,700$721,479$289,222$343,417
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$162
Other NC Liab.$319,418$310,627$22,093$249
Total NC Liab.$816,118$1,032,106$311,315$343,828
Other Liabilities$0$0$0$0
Cap. Leases$42,289$45,186$50,601$40,079
Total Liabilities$871,062$1,090,389$812,176$712,823
Equity
Pref Stock$0$0$0$0
Common Stock$85$67$42$40
Retained Earnings-$3,375,248-$2,961,684-$2,378,488-$1,961,921
AOCI$1,198$10$183$4
Other Equity$2,884,867$2,374,620$1,930,936$1,719,704
Total Equity-$489,098-$586,987-$447,327-$242,173
Supplemental Information
Minority Interest$969$1,050-$2,493-$1,740
Total Liab. & Tot. Equity$382,933$504,452$362,356$468,910
Net Debt$360,738$461,270$619,132$464,563